# FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases

> **NCT07467434** · — · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 550 (estimated)

## Conditions studied

- Rectal Cancer
- Synchronous Liver Metastases
- Antineoplastic Combined Chemotherapy Protocols
- Surgical Therapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07467434
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2030-10
- **Final completion:** 2034-04
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07467434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07467434, "FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07467434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*